Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - MILKY MIST DAIRY FOOD LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) OF EQUITY SHARES TO OPEN ON TUESDAY 11 AUGUST 2026Price Band fixed at ₹133 to ₹140 per equity share of face value of ₹2 each - Shiprocket Limited Announced it's Initial Public Offer (IPO) to open on Wednesday, August 12, 2026 Price Band has been fixed from ₹ 92 to ₹ 97 per Equity Share - Paramotor Digital Technology expands distribution of Digital Prepaid Payment Solutions with Aditya Birla Capital Digital products - Molbio Diagnostics Limited Announced its Initial public offering (IPO) to open on Monday, August 10, 2026 Price Band fixed at ₹ 768 per equity share of face value ₹1 each to ₹ 807 per equity share of the face value of ₹1 each - US Federal Contractor Tryfacta Achieves Final CMMC Level 2 (C3PAO) Certification, Strengthening Its Commitment to the U.S. Defense Industrial Base - Dhoot Transmission Limited Announced its Initial Public Offering (IPO) to open on Monday, August 10, 2026 Price Band fixed at ₹ 829 per equity share of face value ₹2 each to ₹871 per equity share of the face value of ₹2 each - Dhoot Transmission Limited Announced its Initial Public Offering (IPO) to open on Monday, August 10, 2026 Price Band fixed at ₹ 829 per equity share of face value ₹2 each to ₹871 per equity share of the face value of ₹2 each - Ardee Industries Limited Announced its Initial Public Offering (IPO) to open on Wednesday, August 05, 2026Price Band fixed at ₹ 50 per equity share of face value ₹2 each to ₹53 per equity share of the face value of ₹2 each - MS Dhoni Joins Malabar Gold & Diamonds as Brand Ambassador, Strengthening the Responsible Jeweller Promise - Croma opens new store at Sky-City Mall, Borivali, Croma now has 54 stores across the Mumbai Metropolitan Region (MMR)

Quote by Rohitashwa Prasad, Partner, J Sagar Associates on Healthcare & Pharma sector announced by Union Finance Minister Nirmala Sitharaman in the Budget 2021-2022

Mumbai, 01st February 2021 (GNI): Find below quote by Rohitashwa Prasad, Partner, J Sagar Associates on Healthcare & Pharma sector announced by Union Finance Minister Nirmala Sitharaman in the Budget 2021-2022.

“For FY 21 GoI had budgeted Rs. 69,000 crore for healthcare, which was 1.6% of GDP. The budgeted amount for FY 22 shows a significant increase. If this growth were to be extrapolated, the GoI should achieve the target of healthcare spend of 2.5 – 3% of GDP (as envisaged in the National Health Policy 2017) well before its target date.   This is quite promising and clearly illustrates the importance that the GoI is placing on the sector spurred by the Covid pandemic. What is also very commendable is that the GoI has allocated Rs. 35,000 crore for the Covid vaccine as a separate line time. This shows that the GoI has avoided the pitfall of focussing all its resources on tackling communicable diseases at the cost of building healthcare systems generally because of the Covid pandemic, which notwithstanding its materially adverse impact on the health and economy, is an extraordinary event. The GoI has thus avoided the saliency bias which the Economic Survey had warned against.” Rohitashwa Prasad, Partner, J Sagar Associates.ends

Be the first to comment on "Quote by Rohitashwa Prasad, Partner, J Sagar Associates on Healthcare & Pharma sector announced by Union Finance Minister Nirmala Sitharaman in the Budget 2021-2022"

Leave a comment

Your email address will not be published.


*